Mains Guidance Program (MGP) for UPSC CSE 2026, Cohort-1 starts 11th February 2025. Registrations Open Click Here to know more and registration.
News– Researchers from Switzerland have announced the development of a gene-editing technique that may potentially aid in the treatment of Stargardt disease.
About Stargardt Disease
- It is a rare inherited genetic disorder that leads to progressive vision loss, especially in children and young adults.
- Cause: The disease is caused by mutations in the ABCA4 gene, which disrupts the body’s ability to process Vitamin A properly. This leads to the accumulation of lipofuscin, a fatty substance that builds up on the macula—the central part of the retina responsible for sharp, central vision.
- Bilateral: Stargardt disease typically affects both eyes (bilateral), resulting in the gradual loss of central visual acuity in both eyes.
- No Cure: There is currently no cure or effective treatment for Stargardt disease, though research continues to explore potential therapies.
Discover more from Free UPSC IAS Preparation Syllabus and Materials For Aspirants
Subscribe to get the latest posts sent to your email.